Throughout this medical market research, the publisher analyzed 84+ Anesthesia, Respiratory and Sleep Management companies in Europe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this report suite report contains all of the EU15 Anesthesia, Respiratory and Sleep Management market analysis, each of the market segments is also available as a stand-alone a report, MedCore.
Markets Covered
- Anesthesia Monitors Market - Europe - 2021-2027 - MedCore
- Anesthesia Delivery Unit (ADU) Devices Market - Europe - 2021-2027 - MedCore
- Anesthesia Disposables Market - Europe - 2021-2027 - MedCore
- Ventilator Market - Europe - 2021-2027 - MedCore
- Nebulizer Market - Europe - 2021-2027 - MedCore
- Oxygen Therapy Market - Europe - 2021-2027 - MedCore
- Therapeutic Obstructive Sleep Apnea Device Market - Europe - 2021-2027 - MedCore
- Sleep Diagnostic Devices Market - Europe - 2021-2027 - MedCore
Europe Anesthesia, Respiratory and Sleep Management Market Insights
Overall, the European market for anesthesia, respiratory and sleep management devices was valued at nearly €1.9 billion in 2020 and will decline slightly over the forecast period, due to the declining ASPs and market corrections post-COVID offsetting growth in unit sales, to €1.8 billion in 2027.
The ARS market demographic includes surgery patients and senior citizens. With the decline in global air quality, illnesses of the respiratory tract, such as chronic obstructive pulmonary disease (COPD), will increase in incidence. This growth will also affect the ARS market. As the awareness and the frequency of diagnoses, as well as self-diagnoses, increases, so will the population of individuals requiring some form of treatment from this market. In the short term, however, the market was negatively impacted by COVID-19 due to mass cancellations and postponements of surgeries across all countries.
In 2020, ResMed was the leading competitor in the anesthesia, respiratory and sleep management device market. The company led the therapeutic obstructive sleep apnea device market in Europe, with a notable presence in both the sleep therapy interface and PAP device segments. This segment is so large that it positioned ResMed as the overall market leader.
Table of Contents
Table of ContentsList of FiguresList of ChartsExecutive SummaryEuropean Anesthesia, Respiratory and Sleep Management Device Market OverviewCompetitive AnalysisMarket TrendsMarket DevelopmentsMarkets IncludedKey Report UpdatesVersion History
Companies Mentioned
A selection of companies mentioned in this report includes:
- Aeonmed
- Aerogen
- Air Liquide
- AirLife
- AirSep
- Alpha Trace
- Ambu
- Armstrong Medical
- BESCO
- Beurer
- Biurir
- BMC
- Breas
- Ca-Mi
- Becton Dickinson
- Caire
- Clement Clarke
- Compumedics
- CONTEC
- Degmed
- DeVilbiss
- digiO2
- Dräger Medical
- DRE
- Elmaslar
- EVEREST
- EVO Medical
- Fannin
- Farum
- Fisher & Paykel
- Flexicare
- GE Healthcare
- Getinge
- Giotto
- Grass Technologies
- Hamilton Medical
- Hans Rudolph
- HCMedi
- Löwenstein
- Heyer Medical
- Hoffrichter GmbH
- Inogen
- Intersurgical
- Invacare
- Kare
- Lanaform
- Legend
- Linde
- Getinge
- Marshall
- MEDATEC
- Medec
- Medtronic
- Metaltronica
- MGC Diagnostics
- Mindray
- NOX Medical
- NCC
- Neurosoft
- Nihon-Kohden
- Norditalia
- Nouvag
- NOVAPLUS
- Omron
- PARI
- Penlon
- Philips Healthcare
- Planmed
- RanaCareGroup
- ResMed
- Salter Labs
- Schill
- SeQual
- Shinmed
- Siare
- SLE
- Smiths Medical
- SOMNOmedics
- Spacelabs
- Stephan GmbH
- TaiDoc
- Teleflex
- VitalAire
- VyAire
- Weinmann